Literature DB >> 25674238

Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.

Yi Jin1, Yuhui Yu1, Qinshu Shao1, Yingyu Ma2, Ruxuan Zhang2, Haibo Yao1, Yuan Xu1.   

Abstract

OBJECTIVES: The aim of this study was to investigate the expression of ECT2 in gastric cancer and its clinical significance. METHODS AND
RESULTS: We investigated the differentially expressed genes between gastric cancer tissues and normal gastric mucosa by cDNA microarray, and then we found ECT2 was up-regulated in gastric cancer. What is more, we verified ECT2 expression level by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) and measured its protein level by immunohistochemistry (IHC). qRT-PCR analysis indicated ECT2 was significantly up-regulated in gastric cancer and Immunohistochemistry confirmed the percentage of ECT2-positive specimens was significantly higher in gastric carcinoma than in non-tumor tissues. Up-regulation of ECT2 is associated with the degree of histological differentiation (P = 0.007), invasion depth (P = 0.047), lymph node metastasis (P = 0.016), distant metastasis (P = 0.021) and TNM stage (P = 0.016), patients with up-regulated ECT2 had a lower overall survival rate (P = 0.000). Cox regression analysis revealed that up-regulation of ECT2 is an independent prognostic factor in gastric cancer patients (P = 0.012).
CONCLUSION: Up-regulation of ECT2 might contribute to the progression of gastric carcinogenesis and may be a useful prognostic indicator in gastric cancer.

Entities:  

Keywords:  ECT2; gastric cancer; microarray; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25674238      PMCID: PMC4313974     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation.

Authors:  Patricia A Solski; Rhonda S Wilder; Kent L Rossman; John Sondek; Adrienne D Cox; Sharon L Campbell; Channing J Der
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

2.  The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.

Authors:  Lauren P Huff; Molly J Decristo; Dimitri Trembath; Pei Fen Kuan; Margaret Yim; Jinsong Liu; Danielle R Cook; C Ryan Miller; Channing J Der; Adrienne D Cox
Journal:  Genes Cancer       Date:  2013-11

Review 3.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.

Authors:  Kent L Rossman; Channing J Der; John Sondek
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

Review 4.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 5.  Rho GTPase expression in tumourigenesis: evidence for a significant link.

Authors:  Teresa Gómez del Pulgar; Salvador A Benitah; Pilar F Valerón; Carolina Espina; Juan Carlos Lacal
Journal:  Bioessays       Date:  2005-06       Impact factor: 4.345

6.  Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients.

Authors:  Q Zhang; X S Jin; Z Y Yang; M Wei; B Y Liu; Q L Gu
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

Review 7.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 8.  HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Authors:  C Gravalos; A Jimeno
Journal:  Ann Oncol       Date:  2008-04-25       Impact factor: 32.976

9.  Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer.

Authors:  Yuan-Yu Wang; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Shu-Guang Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

10.  Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer.

Authors:  Chun-yu Huang; Jing-jing Zhao; Lin Lv; Yi-bing Chen; Yuan-fang Li; Shan-shan Jiang; Wei Wang; Ke Pan; Yan Zheng; Bai-wei Zhao; Dan-dan Wang; Yong-ming Chen; Lei Yang; Zhi-wei Zhou; Jian-chuan Xia
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more
  15 in total

1.  Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.

Authors:  Verline Justilien; Syed A Ali; Lee Jamieson; Ning Yin; Adrienne D Cox; Channing J Der; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2017-01-19       Impact factor: 31.743

2.  ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer.

Authors:  Xiaoli Liu; Junhua Zhang; Shuang Ju; Lu Liu; Yu Sun; Lingyu Guo; Qianwei Zhen; Sai Han; Wei Lu; Youzhong Zhang
Journal:  Cancer Gene Ther       Date:  2022-09-02       Impact factor: 5.854

3.  Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth.

Authors:  Danielle R Cook; Melissa Kang; Timothy D Martin; Joseph A Galanko; Gabriela H Loeza; Dimitri G Trembath; Verline Justilien; Karen A Pickering; David F Vincent; Armin Jarosch; Philipp Jurmeister; Andrew M Waters; Priya S Hibshman; Andrew D Campbell; Catriona A Ford; Temitope O Keku; Jen Jen Yeh; Michael S Lee; Adrienne D Cox; Alan P Fields; Robert S Sandler; Owen J Sansom; Christine Sers; Antje Schaefer; Channing J Der
Journal:  Cancer Res       Date:  2021-11-04       Impact factor: 13.312

4.  Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.

Authors:  Ce Li; Zhenzi Peng; Yizhou Wang; Gloria Lam; Nicholas Nissen; Jie Tang; Xiaopu Yuan; Michael Lewis; Mark I Greene; Stephen J Pandol; Qiang Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-27       Impact factor: 4.052

5.  Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer.

Authors:  Haisheng Zhang; Antje Schaefer; Channing J Der; Adam J Bass; Yichen Wang; Richard G Hodge; Devon R Blake; J Nathaniel Diehl; Alex G Papageorge; Matthew D Stachler; Jennifer Liao; Jin Zhou; Zhong Wu; Fahire G Akarca; Leonie K de Klerk; Sarah Derks; Mariaelena Pierobon; Katherine A Hoadley; Timothy C Wang; George Church; Kwok-Kin Wong; Emanuel F Petricoin; Adrienne D Cox; Douglas R Lowy
Journal:  Cancer Discov       Date:  2019-11-26       Impact factor: 38.272

6.  Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.

Authors:  Zhiguo Chen; Jiatian Liu; Yihang Zhang
Journal:  Med Sci Monit       Date:  2017-08-10

7.  P53 and Protein Phosphorylation Regulate the Oncogenic Role of Epithelial Cell Transforming 2 (ECT2).

Authors:  Yan Chen; Ping Tian; Yi Liu
Journal:  Med Sci Monit       Date:  2017-06-27

8.  Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.

Authors:  Xianguang Bai; Ming Yi; Xichao Xia; Shengnan Yu; Xinhua Zheng; Kongming Wu
Journal:  Cancer Manag Res       Date:  2018-09-28       Impact factor: 3.989

9.  Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.

Authors:  Qiong Wu; Bo Zhang; Yidan Sun; Ran Xu; Xinyi Hu; Shiqi Ren; Qianqian Ma; Chen Chen; Jian Shu; Fuwei Qi; Ting He; Wei Wang; Ziheng Wang
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

10.  Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells.

Authors:  Hongyi Tan; Xiaoshan Wang; Xiaogang Yang; Haitao Li; Ben Liu; Pinhua Pan
Journal:  Exp Ther Med       Date:  2016-08-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.